Cargando…
Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method
BACKGROUND: Variability in drug response between individual patients is a serious concern in medicine. To identify single-nucleotide polymorphisms (SNPs) related to drug response variability, many genome-wide association studies have been conducted. METHODS: We previously applied a knowledge-based b...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609065/ https://www.ncbi.nlm.nih.gov/pubmed/26475168 http://dx.doi.org/10.1186/s12885-015-1721-z |
_version_ | 1782395759442788352 |
---|---|
author | Takahashi, Hiro Kaniwa, Nahoko Saito, Yoshiro Sai, Kimie Hamaguchi, Tetsuya Shirao, Kuniaki Shimada, Yasuhiro Matsumura, Yasuhiro Ohtsu, Atsushi Yoshino, Takayuki Doi, Toshihiko Takahashi, Anna Odaka, Yoko Okuyama, Misuzu Sawada, Jun-ichi Sakamoto, Hiromi Yoshida, Teruhiko |
author_facet | Takahashi, Hiro Kaniwa, Nahoko Saito, Yoshiro Sai, Kimie Hamaguchi, Tetsuya Shirao, Kuniaki Shimada, Yasuhiro Matsumura, Yasuhiro Ohtsu, Atsushi Yoshino, Takayuki Doi, Toshihiko Takahashi, Anna Odaka, Yoko Okuyama, Misuzu Sawada, Jun-ichi Sakamoto, Hiromi Yoshida, Teruhiko |
author_sort | Takahashi, Hiro |
collection | PubMed |
description | BACKGROUND: Variability in drug response between individual patients is a serious concern in medicine. To identify single-nucleotide polymorphisms (SNPs) related to drug response variability, many genome-wide association studies have been conducted. METHODS: We previously applied a knowledge-based bioinformatic approach to a pharmacogenomics study in which 119 fluoropyrimidine-treated gastric cancer patients were genotyped at 109,365 SNPs using the Illumina Human-1 BeadChip. We identified the SNP rs2293347 in the human epidermal growth factor receptor (EGFR) gene as a novel genetic factor related to chemotherapeutic response. In the present study, we reanalyzed these hypothesis-free genomic data using extended knowledge. RESULTS: We identified rs2867461 in annexin A3 (ANXA3) gene as another candidate. Using logistic regression, we confirmed that the performance of the rs2867461 + rs2293347 model was superior to those of the single factor models. Furthermore, we propose a novel integrated predictive index (iEA) based on these two polymorphisms in EGFR and ANXA3. The p value for iEA was 1.47 × 10(−8) by Fisher’s exact test. Recent studies showed that the mutations in EGFR is associated with high expression of dihydropyrimidine dehydrogenase, which is an inactivating and rate-limiting enzyme for fluoropyrimidine, and suggested that the combination of chemotherapy with fluoropyrimidine and EGFR-targeting agents is effective against EGFR-overexpressing gastric tumors, while ANXA3 overexpression confers resistance to tyrosine kinase inhibitors targeting the EGFR pathway. CONCLUSIONS: These results suggest that the iEA index or a combination of polymorphisms in EGFR and ANXA3 may serve as predictive factors of drug response, and therefore could be useful for optimal selection of chemotherapy regimens. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1721-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4609065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46090652015-10-18 Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method Takahashi, Hiro Kaniwa, Nahoko Saito, Yoshiro Sai, Kimie Hamaguchi, Tetsuya Shirao, Kuniaki Shimada, Yasuhiro Matsumura, Yasuhiro Ohtsu, Atsushi Yoshino, Takayuki Doi, Toshihiko Takahashi, Anna Odaka, Yoko Okuyama, Misuzu Sawada, Jun-ichi Sakamoto, Hiromi Yoshida, Teruhiko BMC Cancer Research Article BACKGROUND: Variability in drug response between individual patients is a serious concern in medicine. To identify single-nucleotide polymorphisms (SNPs) related to drug response variability, many genome-wide association studies have been conducted. METHODS: We previously applied a knowledge-based bioinformatic approach to a pharmacogenomics study in which 119 fluoropyrimidine-treated gastric cancer patients were genotyped at 109,365 SNPs using the Illumina Human-1 BeadChip. We identified the SNP rs2293347 in the human epidermal growth factor receptor (EGFR) gene as a novel genetic factor related to chemotherapeutic response. In the present study, we reanalyzed these hypothesis-free genomic data using extended knowledge. RESULTS: We identified rs2867461 in annexin A3 (ANXA3) gene as another candidate. Using logistic regression, we confirmed that the performance of the rs2867461 + rs2293347 model was superior to those of the single factor models. Furthermore, we propose a novel integrated predictive index (iEA) based on these two polymorphisms in EGFR and ANXA3. The p value for iEA was 1.47 × 10(−8) by Fisher’s exact test. Recent studies showed that the mutations in EGFR is associated with high expression of dihydropyrimidine dehydrogenase, which is an inactivating and rate-limiting enzyme for fluoropyrimidine, and suggested that the combination of chemotherapy with fluoropyrimidine and EGFR-targeting agents is effective against EGFR-overexpressing gastric tumors, while ANXA3 overexpression confers resistance to tyrosine kinase inhibitors targeting the EGFR pathway. CONCLUSIONS: These results suggest that the iEA index or a combination of polymorphisms in EGFR and ANXA3 may serve as predictive factors of drug response, and therefore could be useful for optimal selection of chemotherapy regimens. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1721-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-16 /pmc/articles/PMC4609065/ /pubmed/26475168 http://dx.doi.org/10.1186/s12885-015-1721-z Text en © Takahashi et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Takahashi, Hiro Kaniwa, Nahoko Saito, Yoshiro Sai, Kimie Hamaguchi, Tetsuya Shirao, Kuniaki Shimada, Yasuhiro Matsumura, Yasuhiro Ohtsu, Atsushi Yoshino, Takayuki Doi, Toshihiko Takahashi, Anna Odaka, Yoko Okuyama, Misuzu Sawada, Jun-ichi Sakamoto, Hiromi Yoshida, Teruhiko Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method |
title | Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method |
title_full | Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method |
title_fullStr | Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method |
title_full_unstemmed | Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method |
title_short | Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method |
title_sort | construction of possible integrated predictive index based on egfr and anxa3 polymorphisms for chemotherapy response in fluoropyrimidine-treated japanese gastric cancer patients using a bioinformatic method |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609065/ https://www.ncbi.nlm.nih.gov/pubmed/26475168 http://dx.doi.org/10.1186/s12885-015-1721-z |
work_keys_str_mv | AT takahashihiro constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT kaniwanahoko constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT saitoyoshiro constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT saikimie constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT hamaguchitetsuya constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT shiraokuniaki constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT shimadayasuhiro constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT matsumurayasuhiro constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT ohtsuatsushi constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT yoshinotakayuki constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT doitoshihiko constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT takahashianna constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT odakayoko constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT okuyamamisuzu constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT sawadajunichi constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT sakamotohiromi constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod AT yoshidateruhiko constructionofpossibleintegratedpredictiveindexbasedonegfrandanxa3polymorphismsforchemotherapyresponseinfluoropyrimidinetreatedjapanesegastriccancerpatientsusingabioinformaticmethod |